Free

Multiple Dates

Meet the CEO - Investment meeting with Ducentis Biotherapeutics Ltd.

Event Information

Share this event

Date and Time

Location

Location

19 Eastbourne Terrace

London

W26LG

United Kingdom

View Map

Event description

Description

With considerable lead investment already securred through Oxford Technology, Ducentis BioTherapeutics are raising upto an additional £150k of investment via the Capital Cell platform, before closing their current seed financing round.

Ducentis are developing therapies for inflammatory and autoimmune diseases. Significant mutation of the naturally occurring protein, CD200, has enabled Ducentis to patent a usually unpatentable natural substance, which will be developed to treat rare and commonly occurring autoimmune-mediated inflammatory diseases.

Minimum investment begins at £1k.

View the campaign here, on capitalcell.co.uk


INVESTMENT MEETING

You're invited to meet with Philip Huxley, Ducentis BioTherapeutics CEO, to discover more about the research being conducted by the company, and the market opportunity of this investment.

"Like us, we understand you're very busy, but we'd hate you to miss out on this opportunity, just because you didn't find out about it before the chance was gone. We're inviting you to get to know us and our project, and see if this investment opportunity is one of particular interest to you and you portfolio."


Monday 19th June, 6:30 - 8:00pm (19 Eastbourne Terrace, London)

Friday 23rd June, 12:30 - 2:00pm (19 Eastbourne Terrace, London)

Monday 26th June, 6:30 - 8:00pm (Webinar)


Select the option most suitable for you, and you'll receive all the directions you need (either physical or digital) prior to the event.

Share with friends

Location

19 Eastbourne Terrace

London

W26LG

United Kingdom

View Map

Save This Event

Event Saved